Cardiokol News
2 articles
growth-positive
"תגידו אההההה": קרדיוקול מסייעת לזהות שבץ באמצעות...
Cardiokol, an Israeli health tech startup, has developed a technology that uses voice-based markers to detect strokes. The technology allows for the identification of atrial fibrillation, a common heart rhythm disorder, even before other symptoms appear. The company has conducted clinical trials with over 700 participants, most of them in Israel, and the results indicate success in identifying the disease. Cardiokol has raised $8 million in a seed funding round from KAMET and several private investors. The company is now preparing for a Series A funding round, aiming to raise $15 million.
InvestmentExpand
growth-positive
Nine digital health pioneers to join Bayer's G4A program
Bayer has accepted nine companies into its Digital Health Partnership Program, focusing on mental health, cardiometabolic and renal diseases, radiology, and womens health. Four startups have joined the program through Bayers G4A Growth Track, receiving €100,000 each for market uptake and mentoring. The funded startups include Cardiokol, Acorai, Pollie, and RCubeHealth. Additionally, five companies have been selected for commercial partnerships through Bayers G4A Advanced Track, including Liva Healthcare, Cordio Medical, Nines, Woebot Health, and Zed Technologies. Bayer aims to accelerate R&D in digital health through these investments. The companys G4A program has supported over 150 European healthcare technology companies through partnerships, collaborations, and investments.
Partners
